150 related articles for article (PubMed ID: 35637462)
21. Identification and Validation of Prognostically Relevant Gene Signature in Melanoma.
Gao Y; Li Y; Niu X; Wu Y; Guan X; Hong Y; Chen H; Song B
Biomed Res Int; 2020; 2020():5323614. PubMed ID: 32462000
[TBL] [Abstract][Full Text] [Related]
22. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
Wang K; Li Y; Wang J; Chen R; Li J
Clin Transl Oncol; 2021 Nov; 23(11):2368-2381. PubMed ID: 34028782
[TBL] [Abstract][Full Text] [Related]
23. Genome-Wide Scan for Copy Number Alteration Association with Relapse-Free Survival in Colorectal Cancer with Liver Metastasis Patients.
Yang PS; Hsu HH; Hsu TC; Chen MJ; Wang CD; Yu SL; Hsu YC; Li KC
J Clin Med; 2018 Nov; 7(11):. PubMed ID: 30453668
[TBL] [Abstract][Full Text] [Related]
24. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
26. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma.
Yu J; Yang K; Zheng J; Sun X; Zhao W
Gene; 2022 Jan; 808():145990. PubMed ID: 34624456
[TBL] [Abstract][Full Text] [Related]
27. Identification of seven-gene marker to predict the survival of patients with lung adenocarcinoma using integrated multi-omics data analysis.
Zhang S; Zeng X; Lin S; Liang M; Huang H
J Clin Lab Anal; 2022 Feb; 36(2):e24190. PubMed ID: 34951053
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
29. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
Zhang J; Zhang S; Wang Y; Zhang XS
BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a novel mRNA signature for predicting early relapse in non-small cell lung cancer.
Lin J; Weng J; Lin S; Lin C; Huang J; Zhang C; Zhang S; Dong C; Ji H; Ke X
Jpn J Clin Oncol; 2021 Aug; 51(8):1277-1286. PubMed ID: 34037221
[TBL] [Abstract][Full Text] [Related]
31. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Zou X; Hu Z; Huang C; Chang J
Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
[TBL] [Abstract][Full Text] [Related]
32. Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers.
Ghatak S; Mehrabi SF; Mehdawi LM; Satapathy SR; Sjölander A
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054980
[TBL] [Abstract][Full Text] [Related]
33. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK
Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430
[TBL] [Abstract][Full Text] [Related]
34. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
35. Introducing a novel and robust technique for determining lymph node status in colorectal cancer.
Hogan J; Judge C; O'Callaghan M; Aziz A; O'Connor C; Burke J; Dunne C; Walsh S; Kalady M; Coffey JC
Ann Surg; 2014 Jul; 260(1):94-102. PubMed ID: 24169164
[TBL] [Abstract][Full Text] [Related]
36. Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers.
Xu M; Yuan L; Wang Y; Chen S; Zhang L; Zhang X
Pathol Oncol Res; 2021; 27():1609784. PubMed ID: 34366718
[No Abstract] [Full Text] [Related]
37. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data.
Kok-Sin T; Mokhtar NM; Ali Hassan NZ; Sagap I; Mohamed Rose I; Harun R; Jamal R
Oncol Rep; 2015 Jul; 34(1):22-32. PubMed ID: 25997610
[TBL] [Abstract][Full Text] [Related]
38. A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency.
Tian S; Roepman P; Popovici V; Michaut M; Majewski I; Salazar R; Santos C; Rosenberg R; Nitsche U; Mesker WE; Bruin S; Tejpar S; Delorenzi M; Bernards R; Simon I
J Pathol; 2012 Dec; 228(4):586-95. PubMed ID: 22926706
[TBL] [Abstract][Full Text] [Related]
39. A robust gene signature for the prediction of early relapse in stage I-III colon cancer.
Dai W; Li Y; Mo S; Feng Y; Zhang L; Xu Y; Li Q; Cai G
Mol Oncol; 2018 Apr; 12(4):463-475. PubMed ID: 29377588
[TBL] [Abstract][Full Text] [Related]
40. A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.
Cao B; Luo L; Feng L; Ma S; Chen T; Ren Y; Zha X; Cheng S; Zhang K; Chen C
BMC Cancer; 2017 Dec; 17(1):844. PubMed ID: 29237416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
